Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS
BackgroundRecent studies proposed cellular immunoprofiling as a surrogate for predicting treatment response and/or stratifying the occurrence of adverse events (AEs) in persons with multiple sclerosis (pwMS). However, applicability in real-world circumstances is not sufficiently addressed.ObjectiveW...
Main Authors: | Tobias Zrzavy, Kerstin Rieder, Viktoria Wuketich, Renate Thalhammer, Helmuth Haslacher, Patrick Altmann, Barbara Kornek, Nik Krajnc, Tobias Monschein, Christiane Schmied, Karin Zebenholzer, Gudrun Zulehner, Thomas Berger, Paulus Rommer, Fritz Leutmezer, Gabriel Bsteh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1388941/full |
Similar Items
-
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial
by: Patrick Altmann, et al.
Published: (2022-11-01) -
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
by: Altmann, Patrick, et al.
Published: (2021-05-01) -
Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
by: Patrick Altmann, et al.
Published: (2021-02-01) -
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
by: Nik Krajnc, et al.
Published: (2022-06-01) -
Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
by: Patrick Altmann, et al.
Published: (2022-07-01)